A COVID-19 drug made from a ‘cocktail’ of two types of antibodies were effective against coronavirus variants, a new study suggests.
Researchers found that combining two of three monoclonal antibodies made by Eli Lilly & Co, Regeneron or Vir Biotechnology Inc were effective more infectious strains first identified in the UK, South Africa, Brazil and India.
Antibodies are used to treat cases of COVID-19, often early in the process including on former President Donald Trump after he tested positive in October,
Read more of the original article from DailyMail
